Navigation Links
Pixantrone Produces High Rates of Complete and Partial Remissions Even Among Aggressive NHL Patients With Extensive Prior Doxorubicin Treatment or Prior Rituximab Treatment
Date:6/1/2009

Cycle No. of Patients Pixantrone Lifetime Treatment Cumulative Cumulative Dose Dose Median mg/m2 Median mg/m2 1 68 74 365.2 2 54 148 430.2 3 43 209 498.1 4 36 275 571.8 5 25 356 631.5 6 22 427 695.0

Lifetime doses of doxorubicin of over 550 mg/m2 are associated with a high incidence of CHF if the cumulative dose levels were solely with a standard anthracycline.

An additional new subgroup analysis was highlighted by the ASCO discussant, which demonstrated the clinical benefit associated with achieving a CR or CRu with pixantrone. On an intent-to-treat basis, patients achieving a CR/CRu on the pixantrone treatment arm (n=14) had a significant increase in the duration of remission compared with the four patients who achieved a CRu with standard chemotherapy (7 months vs. 3.5 months, p=0.03, HR=0.279; a hazard ratio of less than one indicates a decreased risk of disease progression and a p-value of less than 0.05 indicates statistical significance).

An analysis was also reported that evaluated the effect of prior rituximab therapy on response rates. In the 38 patients who received pixantrone following prior treatment with rituximab, 12 patients (32%) achieved a CR/CRu/PR of which six patients (16%) achieved a CR/CRu. In the comparator arm, the response rate was seven out of 39 patients (18%) with three CRu.

The discussant noted that overall respons
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting
2. Compared to Standard Therapies, Pixantrone Decreases Time to Achieve Complete Remission by 47% in Relapsed Aggressive Non-Hodgkins Lymphoma
3. Cell Therapeutics and IDIS Announce Agreement for a European Named Patient/Compassionate Use Program for Pixantrone
4. Pixantrone Increases Progression-Free Survival by 81% Compared to Standard Chemotherapeutic Agents in Phase III Relapsed Aggressive non-Hodgkins Lymphoma Trial
5. Pixantrone Pre-NDA Communication from FDA Provides Cell Therapeutics Basis to Begin Rolling NDA Submission
6. Cell Therapeutics Pixantrone Phase III (EXTEND) Pivotal Trial Successful in Achieving Primary Endpoint
7. Cell Therapeutics Announces Study Data Set Cut-off for Phase III Pivotal Pixantrone (301) Trial
8. Cell Therapeutics, Inc. (CTI) Announces Enrollment Complete in Phase III EXTEND (PIX301) Clinical Trial of Pixantrone in Patients With Second or Greater Relapse of Diffuse Large B Cell NHL
9. Pixantrone to be Studied in Phase I/II Trial for Aggressive Multiple Sclerosis
10. Pixantrone Shows Activity in a Preclinical Study of Experimental Autoimmune Myasthenia Gravis (EAMG)
11. Pixantrone Versus Doxorubicin in CHOP-R Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Preliminary Results Presented at American Society of Hematology (ASH) Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... NEW YORK , July 30, 2015 ... releases a new research report with market ... size, share, forecast, porter analysis, recent developments, ... Global Industry Insight: Biosensors Market ...      (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) ...
(Date:7/30/2015)... AUSTIN, Texas , July 30, 2015 ... solutions company focused on gynecologic disease, announced ... 2015 financial results after the market close ... an investor conference call and webcast at ... August 13, 2015 at 4:30pm Eastern/1:30pm Pacific  ...
(Date:7/30/2015)... 30, 2015 What can be ... areas are going to grow at the fastest rates? ... revenues to 2025, assessing data, trends, opportunities and prospects ... 176 tables, charts, and graphs. Discover the most lucrative ... Our new study lets you assess forecasted sales at ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 2Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 3Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 4Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 5Ophthalmic Devices Market Forecast 2015-2025 - Future Prospects for Leading Companies in Vision Care, Surgical, Diagnostic & Monitoring Devices 6
(Date:7/31/2015)... , ... July 31, 2015 , ... Physical therapy for knee osteoarthritis ... patient's quality of life. It keeps the patient from doing what they want or need ... have a hard time using the stairs. The patient's exercise regime may be limited by ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... 100% organic, natural, therapeutic-grade oils from ingredients sourced all over the world, then ... “With considerable effort, we have developed the highest-quality oils in the industry, which ...
(Date:7/31/2015)... ... ... “ Crack’em ” was featured on NewsWatch as part of its monthly ... Forstrom, a technology expert and special reporter for NewsWatch, conducted the review and shared ... can be a very messy experience, especially when cracking eggs. Cracking an egg is ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... wide variety of nutritional and wellness products, announced the addition of Vincent Aquilino ... massage therapy, active isolated stretching and the prevention and rehabilitation of injuries, has ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... care client base, with the recent implementation of Microsoft Dynamics GP for a ... the industry, Intellitec is now supporting senior living communities in 16 states. This ...
Breaking Medicine News(10 mins):Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 2Health News:NYDNRehab Is the First Clinic in NYC to Provide APOS Therapy Based on Results of Complete Gait Analysis 3Health News:Living Pure Essential Oils takes Therepeutic Essential Oil Market by Storm 2Health News:Make Less Mess while Cooking with Crack’em 2Health News:NPI Welcomes Vincent Aquilino to Board of Directors 2Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2
... MONDAY, Aug. 16 (HealthDay News) -- A new study finds that ... lower than what their wife or female partner makes, while women ... their husband or male partner. The findings suggest that disparities ... the young couples they studied. "With women, they were less ...
... We all want that summer glow that comes from a day ... implications for our health. Now Dr. Niva Shapira of Tel Aviv ... in the sun safer ― and it,s all in our food. ... Dr. Shapira has shown that a diet rich in antioxidants and ...
... 2010 Young adults who abuse amphetamines may be at ... leading from the heart, UT Southwestern Medical Center researchers have ... of American Heart Journal , researchers examined medical records ... old hospitalized from 1995 to 2007 and found that amphetamine ...
... assesses donor characteristics impacting liver transplantation outcomes, does not bear ... is suggested from large-scale, national data. Rather, hepatitis ... to poor graft survival in transplant patients, according to a ... were to confirm the effect of the Donor Risk Index ...
... implications for developing treatments against cancer and potentially deadly ... the function of proteins that can enhance the progression ... published in the journal Genes and Development . ... professor of cell biology, and Christopher Hellen, DPhil, associate ...
... researchers found that terminology and efforts to frame an ... have no effect on public opinion concerning the ongoing ... Using an experimental approach involving a nationally representative sample, ... not rhetoric, such as the use of ,same-sex couple, ...
Cached Medicine News:Health News:Infidelity Rises When She Makes More Than He Does 2Health News:Infidelity Rises When She Makes More Than He Does 3Health News:SPF on your plate 2Health News:SPF on your plate 3Health News:Amphetamine use increases risk of aortic tears in young adults, UT Southwestern researchers report 2Health News:Henry Ford Hospital study: Donor Risk Index does not impact outcomes on a small scale 2Health News:Researchers find function of proteins that can enhance the progression of viruses and cancer cells 2Health News:Rhetoric, framing efforts have little influence in same-sex marriage debate 2
... DrDrugs®: Drug Guide ... with over 760 Integrated ... most comprehensive, up-to-date and ... built in drug dosing ...
Clinician's Pocket Drug Reference 2005 includes key elements of commonly used medications that are essential information for both the student and practicing physician....
... of the authoritative 2005 edition ... Code of Federal Regulations (CFR) ... published in the Federal Register. ... released by the Government Printing ...
... The Quality Module QS I evaluates ... of centrifuged serum samples. The System ... and recognizes if a sample contains ... with the Aliquoting System RSD 800A ...
Medicine Products: